Cargando…

FOXA1 inhibits prostate cancer neuroendocrine differentiation

Neuroendocrine prostate cancer (NEPC) has increasingly become a clinical challenge. The mechanisms by which neuroendocrine (NE) cells arises from prostate adenocarcinoma cells are poorly understood. FOXA1 is a transcription factor of the forkhead family that is required for prostate epithelial diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jung, Jin, Hongjian, Zhao, Jonathan C., Yang, Yeqing A., Li, Yinan, Yang, Ximing, Dong, Xuesen, Yu, Jindan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509480/ https://www.ncbi.nlm.nih.gov/pubmed/28319070 http://dx.doi.org/10.1038/onc.2017.50

Ejemplares similares

Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer
por: Yang, Yeqing Angela, et al.
Publicado: (2015)

FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression
por: Zhao, Jonathan C., et al.
Publicado: (2016)

Epithelial Transcription Factor FOXA1 Regulates Prostate Cancer Immune Response
por: Brea, Lourdes T, et al.
Publicado: (2021)

Cooperativity and Equilibrium with FOXA1 Define the Androgen Receptor Transcriptional Program
por: Jin, Hong-Jian, et al.
Publicado: (2014)

FOXA1 potentiates lineage-specific enhancer activation through modulating TET1 expression and function
por: Yang, Yeqing A., et al.
Publicado: (2016)

Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells
por: Chen, Ruiqui, et al.
Publicado: (2017)

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer
por: Baca, Sylvan C., et al.
Publicado: (2021)

Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells
por: Chen, Ruiqi, et al.
Publicado: (2018)

FOXA1 in prostate cancer
por: Dong, Hui-Yu, et al.
Publicado: (2022)

Influence of oncogenic transcription factors on chromatin conformation and implications in prostate cancer
por: Yang, Yeqing Angela, et al.
Publicado: (2014)

FOXA2 is a Sensitive and Specific marker for Small Cell Neuroendocrine Carcinoma of the Prostate
por: Park, Jung Wook, et al.
Publicado: (2017)

THU479 FOXA1 Loss Remodels The Tumor Immune Microenvironment In Late-stage Prostate Cancer
por: Brea, Lourdes T, et al.
Publicado: (2023)

Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2
por: Liu, Qiuli, et al.
Publicado: (2020)

Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer
por: Park, Su H., et al.
Publicado: (2021)

MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer
por: Zeng, Fanchang, et al.
Publicado: (2023)

Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression
por: Lee, Ahn R., et al.
Publicado: (2017)

Perspectives on Circular RNAs as Prostate Cancer Biomarkers
por: Fang, Jiajie, et al.
Publicado: (2020)

FOXA1 mutations alter pioneering activity, differentiation, and prostate cancer phenotypes
por: Adams, Elizabeth J., et al.
Publicado: (2019)

Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4
por: Li, Yinan, et al.
Publicado: (2017)

Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor Gene
por: Luo, Jindan, et al.
Publicado: (2019)

LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer
por: Zhang, Ali, et al.
Publicado: (2015)

FOXA1 regulates alternative splicing in prostate cancer
por: Del Giudice, Marco, et al.
Publicado: (2022)

Frequent mutation of the FOXA1 untranslated region in prostate cancer
por: Annala, Matti, et al.
Publicado: (2018)

Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer
por: Gan, Yu, et al.
Publicado: (2018)

Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
por: Zhao, Yu, et al.
Publicado: (2014)

Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer
por: Lee, Ahn R., et al.
Publicado: (2018)

c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer
por: Maina, Peterson Kariuki, et al.
Publicado: (2016)

Pioneer of prostate cancer: past, present and the future of FOXA1
por: Teng, Mona, et al.
Publicado: (2020)

A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network
por: Lee, Ahn R., et al.
Publicado: (2018)

Development of Neuroendocrine Prostate Cancers by the Ser/Arg Repetitive Matrix 4-Mediated RNA Splicing Network
por: Lee, Ahn R., et al.
Publicado: (2018)

Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs
por: Maier, Jennifer A., et al.
Publicado: (2013)

Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275>
por: Gan, Yu, et al.
Publicado: (2020)

Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
por: Parolia, Abhijit, et al.
Publicado: (2019)

Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer
por: Gao, Shuai, et al.
Publicado: (2020)

Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth
por: Gritsina, Galina, et al.
Publicado: (2023)

Prostate cancer with neuroendocrine differentiation – case report
por: Glück, G, et al.
Publicado: (2012)

FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer
por: Camolotto, Soledad A, et al.
Publicado: (2018)

FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation
por: Lee, Kihyun, et al.
Publicado: (2019)

FoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate Cancer
por: Robinson, Jessica L. L., et al.
Publicado: (2012)

Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer
por: Zhou, Stanley, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4hq34ekvmsr941mlmoosvih2d0